Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Development and characterization of a stable luciferase dengue virus for high-throughput screening.

Zou G, Xu HY, Qing M, Wang QY, Shi PY.

Antiviral Res. 2011 Jul;91(1):11-9. doi: 10.1016/j.antiviral.2011.05.001. Epub 2011 May 7.

PMID:
21575658
2.

A high-throughput assay using dengue-1 virus-like particles for drug discovery.

Qing M, Liu W, Yuan Z, Gu F, Shi PY.

Antiviral Res. 2010 May;86(2):163-71. doi: 10.1016/j.antiviral.2010.02.313. Epub 2010 Feb 12.

PMID:
20153777
3.

Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.

Yang CC, Tsai MH, Hu HS, Pu SY, Wu RH, Wu SH, Lin HM, Song JS, Chao YS, Yueh A.

Antiviral Res. 2013 May;98(2):228-41. doi: 10.1016/j.antiviral.2013.03.001. Epub 2013 Mar 13.

PMID:
23499649
4.

Development and characterization of a stable eGFP enterovirus 71 for antiviral screening.

Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B.

Antiviral Res. 2013 Feb;97(2):198-205. doi: 10.1016/j.antiviral.2012.12.010. Epub 2012 Dec 22.

PMID:
23267829
5.

Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.

Kato F, Kobayashi T, Tajima S, Takasaki T, Miura T, Igarashi T, Hishiki T.

Jpn J Infect Dis. 2014;67(3):209-12.

6.

Identification of a small-molecule inhibitor of dengue virus using a replicon system.

Hsu YC, Chen NC, Chen PC, Wang CC, Cheng WC, Wu HN.

Arch Virol. 2012 Apr;157(4):681-8. doi: 10.1007/s00705-012-1224-z. Epub 2012 Jan 15.

PMID:
22249364
7.

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.

van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.

Antiviral Res. 2013 Aug;99(2):165-71. doi: 10.1016/j.antiviral.2013.05.011. Epub 2013 Jun 2.

PMID:
23735301
8.

High-throughput screening using dengue virus reporter genomes.

Fischl W, Bartenschlager R.

Methods Mol Biol. 2013;1030:205-19. doi: 10.1007/978-1-62703-484-5_17.

PMID:
23821271
9.

Development of a stable Gaussia luciferase enterovirus 71 reporter virus.

Xu LL, Shan C, Deng CL, Li XD, Shang BD, Ye HQ, Liu SQ, Yuan ZM, Wang QY, Shi PY, Zhang B.

J Virol Methods. 2015 Jul;219:62-6. doi: 10.1016/j.jviromet.2015.03.020. Epub 2015 Apr 2.

PMID:
25843263
10.

Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.

Yu L, Aoki C, Shimizu Y, Shimizu K, Hou W, Yagyu F, Wen X, Oshima M, Iwamoto A, Gao B, Liu W, Gao GF, Kitamura Y.

J Virol Methods. 2010 Nov;169(2):380-4. doi: 10.1016/j.jviromet.2010.08.009. Epub 2010 Aug 14.

PMID:
20713089
11.

Establishment of a stable cell line coexpressing dengue virus-2 and green fluorescent protein for screening of antiviral compounds.

Leardkamolkarn V, Sirigulpanit W.

J Biomol Screen. 2012 Mar;17(3):283-92. doi: 10.1177/1087057111426903. Epub 2011 Nov 7.

PMID:
22068705
12.

Narasin, a novel antiviral compound that blocks dengue virus protein expression.

Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.

Antivir Ther. 2011;16(8):1203-18. doi: 10.3851/IMP1884.

PMID:
22155902
13.

Inhibition of dengue virus by targeting viral NS4B protein.

Xie X, Wang QY, Xu HY, Qing M, Kramer L, Yuan Z, Shi PY.

J Virol. 2011 Nov;85(21):11183-95. doi: 10.1128/JVI.05468-11. Epub 2011 Aug 24.

14.

Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.

Smith TM, Lim SP, Yue K, Busby SA, Arora R, Seh CC, Wright SK, Nutiu R, Niyomrattanakit P, Wan KF, Beer D, Shi PY, Benson TE.

J Biomol Screen. 2015 Jan;20(1):153-63. doi: 10.1177/1087057114551141. Epub 2014 Sep 24.

PMID:
25252731
15.

Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.

Yang CC, Hsieh YC, Lee SJ, Wu SH, Liao CL, Tsao CH, Chao YS, Chern JH, Wu CP, Yueh A.

Antimicrob Agents Chemother. 2011 Jan;55(1):229-38. doi: 10.1128/AAC.00855-10. Epub 2010 Oct 11.

16.

A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.

Yang CC, Hu HS, Wu RH, Wu SH, Lee SJ, Jiaang WT, Chern JH, Huang ZS, Wu HN, Chang CM, Yueh A.

Antimicrob Agents Chemother. 2014;58(1):110-9. doi: 10.1128/AAC.01281-13. Epub 2013 Oct 21.

17.

Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14610-5. doi: 10.1073/pnas.1212379109. Epub 2012 Aug 20.

18.

The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery.

Anwar A, Leong KM, Ng ML, Chu JJ, Garcia-Blanco MA.

J Biol Chem. 2009 Jun 19;284(25):17021-9. doi: 10.1074/jbc.M109.006239. Epub 2009 Apr 20.

19.

Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Hao W, Herlihy KJ, Zhang NJ, Fuhrman SA, Doan C, Patick AK, Duggal R.

Antimicrob Agents Chemother. 2007 Jan;51(1):95-102. Epub 2006 Oct 23.

20.

Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.

Farias KJ, Machado PR, da Fonseca BA.

ScientificWorldJournal. 2013;2013:282734. doi: 10.1155/2013/282734. Epub 2013 Jan 31.

Supplemental Content

Support Center